New Mayo Clinic representatives nominated to NCCN guidelines panels

Additional Mayo Clinic representatives have been chosen for National Comprehensive Cancer Network (NCCN) guidelines panels.

Daniel Ahn, D.O. (HEMO ’17), Division of Hematology and Medical Oncology, Mayo Clinic in Arizona, NCCN Occult Primary Panel

Wendy Allen-Rhoades, M.D., Ph.D. (PD ’20), Division of Pediatric Hematology/Oncology, Mayo Clinic in Rochester, NCCN Adolescent and Young Adult Panel

Aminah Jatoi, M.D. (ONCL ’98), Division of Medical Oncology, Mayo Clinic in Rochester, NCCN Older Adult Panel

Mira Kohorst, M.D. (MED ’13, PD ’16, PDHO ’19), Division of Pediatric Hematology/Oncology, Mayo Clinic in Rochester, NCCN Pediatric Acute Lymphoblastic Leukemia Panel

Mark Tyson, M.D. (PRES ’11, U ’15), Department of Urology, Mayo Clinic in Arizona, NCCN Prostate Cancer Early Detection Panel

The NCCN is a nonprofit alliance of leading cancer centers dedicated to improving the quality, effectiveness and efficiency of care for cancer patients. The Mayo Clinic Cancer Center was elected to NCCN membership in 2014.

NCCN membership offers Mayo Clinic Cancer Center the opportunity to work with leadership and clinical professionals at other NCCN member institutions to create clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision makers. The NCCN Guidelines carry significant influence over the practice of cancer medicine and provider reimbursement, not only in the U.S., but internationally.

View a complete list of Mayo Clinic representatives serving on NCCN guidelines panels.